2010
DOI: 10.1016/j.jchemneu.2009.12.002
|View full text |Cite
|
Sign up to set email alerts
|

Rapid loss of glutamine synthetase from astrocytes in response to hypoxia: Implications for excitotoxicity

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

2
21
0

Year Published

2012
2012
2017
2017

Publication Types

Select...
7
2

Relationship

1
8

Authors

Journals

citations
Cited by 38 publications
(23 citation statements)
references
References 30 publications
2
21
0
Order By: Relevance
“…Moreover, there is an increase in metabolic activity in the liver since arginase was profoundly increased. Arginase is involved in the last step of the urea cycle in which toxic ammonia is converted to urea, which takes place in the cytoplasm of the liver [57,58,59]. We suggest that the increase in hepatic arginase could be used as a marker for increased hepatic metabolism after HI.…”
Section: Discussionmentioning
confidence: 99%
“…Moreover, there is an increase in metabolic activity in the liver since arginase was profoundly increased. Arginase is involved in the last step of the urea cycle in which toxic ammonia is converted to urea, which takes place in the cytoplasm of the liver [57,58,59]. We suggest that the increase in hepatic arginase could be used as a marker for increased hepatic metabolism after HI.…”
Section: Discussionmentioning
confidence: 99%
“…With few exceptions, glutamine synthetase activity is either restored or increased following ischemia and during [82] Shown are the effects of various stroke models on glutamine synthetase specific activity, amounts, and where measured: mRNA. The amounts of glutamine were determined by specific activity measurements (reported as activity in the table), electron microscopy (EM), Western blotting (WB), and immunohistochemistry (IMH).…”
Section: Glutamine Synthetase and Strokementioning
confidence: 99%
“…The amounts of glutamine were determined by specific activity measurements (reported as activity in the table), electron microscopy (EM), Western blotting (WB), and immunohistochemistry (IMH). No change, increases or decreases are indicated by blue, green and red lettering, respectively a References Neurochem Res reperfusion [63,64,[72][73][74][75][76][77][78][79][80][81][82] (Table 1). These changes occurred notwithstanding the production of both the Á NO and hydroxyl radicals as measured directly by EPR [67,68] and indirectly by other measures [64,73,75,76,[78][79][80][81].…”
Section: Glutamine Synthetase and Strokementioning
confidence: 99%
“…Notably, gene deletion, gene knockdown, and pharmacological studies have indicated that the glutamate transporter-1 (GLT-1) subtype may contribute up to 90% of total transport in the forebrain, while inhibition of GLT-1 leads to severe neurological deficits and larger infarction volume (10,11). Furthermore, the intracellular glutamate is degraded by glutamine synthetase (GS), which accelerates glutamate transportation (12 of GS significantly impaired glutamate uptake and resulted in increased excitotoxicity to neurons (13). Therefore, GLT-1 and GS contribute to glutamate metabolism collectively.…”
Section: Introductionmentioning
confidence: 99%